Invasive pulmonary fungal infections in children with severe human adenovirus type 7 pneumonia: A retrospective study

P Q Huang1, H Du2, H B Chen2

  • 1Department of Electrocardiogram, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, 430014, China.

Insights

Human adenovirus type 7 (HAdV-7) and invasive pulmonary fungal infections (IPFIs) co-infection is increasing. Aspergillus is the most common fungus in severe HAdV-7 pneumonia with IPFIs, requiring early prediction in vulnerable children.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Rising incidence of co-infection between human adenovirus type 7 (HAdV-7) and invasive pulmonary fungal infections (IPFIs).
  • Need to understand clinical characteristics of severe HAdV-7 pneumonia complicated by IPFIs.

Purpose of the Study:

  • To explore clinical characteristics of severe HAdV-7 pneumonia combined with IPFIs.
  • To identify common fungal species and patient factors associated with co-infection.

Main Methods:

  • Retrospective study of patients with confirmed HAdV-7 infection from 2018-2019.
  • Comparison of clinical data between patients with and without IPFIs.

Main Results:

  • 35 out of 143 patients had IPFIs co-infection.
  • Aspergillus was the most common fungal species.
  • IPFIs group showed higher rates of respiratory failure, heart failure, and hemophagocytic syndrome, with lower WBC, CD3+, and CD19+ lymphocyte counts.

Conclusions:

  • Aspergillus is the predominant fungus in HAdV-7 pneumonia with IPFIs.
  • Early prediction of IPFIs in pediatric severe HAdV-7 pneumonia is crucial for younger patients with prolonged illness, ICU admission, multi-system dysfunction, and reduced lymphocyte counts.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
357
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
476
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
737
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
405
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
365
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
360